Back to Search

RONALD EMKEY, M.D.

M.D.

Rheumatology Physician

NPI: 1265592414Individual

Specialties, Licenses & Credentials

Rheumatology PhysicianPrimary

Internal Medicine — Rheumatology

Code: 207RR0500X

MD008733E(PA)

Research & Publications (20)

Efficacy and tolerability of once-monthly oral ibandronate (150 mg) and once-weekly oral alendronate (70 mg): additional results from the Monthly Oral Therapy With Ibandronate For Osteoporosis Intervention (MOTION) study.
PMID 19446148·Clin Ther·2009
4-observational
Quarterly intravenous ibandronate for postmenopausal osteoporosis.
PMID 19072470·Womens Health (Lond)·2008
6-review
Improving compliance and persistence with bisphosphonate therapy for osteoporosis.
PMID 16563937·Am J Med·2006
6-review
Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO).
PMID 16368038·Curr Med Res Opin·2005
4-observational
Alendronate and risedronate for the treatment of postmenopausal osteoporosis: clinical profiles of the once-weekly and once-daily dosing formulations.
PMID 15520628·MedGenMed·2004
6-review
Efficacy and safety of tramadol/acetaminophen tablets (Ultracet) as add-on therapy for osteoarthritis pain in subjects receiving a COX-2 nonsteroidal antiinflammatory drug: a multicenter, randomized, double-blind, placebo-controlled trial.
PMID 14705234·J Rheumatol·2004
3-trial
Changes in bone mineral density following discontinuation or continuation of alendronate therapy in glucocorticoid-treated patients: a retrospective, observational study.
PMID 12687554·Arthritis Rheum·2003
3-trial
Screening G protein-coupled receptors: measurement of intracellular calcium using the fluorometric imaging plate reader.
PMID 19551361·Methods Mol Biol·2009
7-preclinical
Discovery of alpha-amidosulfones as potent and selective agonists of CB2: synthesis, SAR, and pharmacokinetic properties.
PMID 19062274·Bioorg Med Chem Lett·2009
7-preclinical
Ibandronate dose response is associated with increases in bone mineral density and reductions in clinical fractures: results of a meta-analysis.
PMID 19049913·Bone·2009
1-meta
Discovery and optimization of a novel series of N-arylamide oxadiazoles as potent, highly selective and orally bioavailable cannabinoid receptor 2 (CB2) agonists.
PMID 18680277·J Med Chem·2008
7-preclinical
Structural modifications of N-arylamide oxadiazoles: Identification of N-arylpiperidine oxadiazoles as potent and selective agonists of CB2.
PMID 18640038·Bioorg Med Chem Lett·2008
7-preclinical
Optimization and utilization of the SureFire phospho-STAT5 assay for a cell-based screening campaign.
PMID 18336085·Assay Drug Dev Technol·2008
8-other
Double-blind trial of recombinant gamma-interferon versus placebo in the treatment of rheumatoid arthritis. 1989.
PMID 18240222·Arthritis Rheum·2008
8-other
Safety considerations with bisphosphonates for the treatment of osteoporosis.
PMID 17722968·Drug Saf·2007
6-review
Oral ibandronate in the management of postmenopausal osteoporosis: review of upper gastrointestinal safety.
PMID 16522358·Maturitas·2006
6-review
Alendronate with and without cholecalciferol for osteoporosis: results of a 15-week randomized controlled trial.
PMID 16968578·Curr Med Res Opin·2006
3-trial
Identification and pharmacological profile of a new class of selective nicotinic acetylcholine receptor potentiators.
PMID 16738207·J Pharmacol Exp Ther·2006
7-preclinical
Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study.
PMID 16339289·Ann Rheum Dis·2006
3-trial
Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s).
PMID 15717213·Psychopharmacology (Berl)·2005
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
1200 BROADCASTING RD, SUITE 200
WYOMISSING, PA 19610

Location

Practice Location

1200 BROADCASTING RD, WYOMISSING, PA
(610) 374-8133

Quick Facts

NPI
1265592414
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile